日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma

IRF4促进滤泡性淋巴瘤的免疫逃逸并塑造肿瘤微环境

Surendra Dasari ,Kerstin Wenzl ,Geoffrey M Nelson ,Emmanuel Contreras Guzman ,Zhiquan Wang ,Loic Chartier ,Zhi-Zhang Yang ,Jose C Villasboas ,Joshua Olson ,Prithviraj Mukherjee ,Vaishali Bhardwaj ,Xinyi Tang ,Brianna J Negaard ,Johannes L Zakrzewski ,Rebecca L King ,Sarah Huet ,Bruno Tesson ,Matthew J Maurer ,Franck Morschhauser ,Grzegorz S Nowakowski ,Karen L Adelman ,Harinder Singh ,Laura Pasqualucci ,Mark Shlomchik ,Anne J Novak ,Stephen M Ansell ,Patrizia Mondello

Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation

弥漫性大B细胞淋巴瘤的转录组分类识别出具有可靶向MYC失调的高危活化B细胞样亚群

Matthew E Stokes,Kerstin Wenzl,C Chris Huang,María Ortiz,Chih-Chao Hsu,Matthew J Maurer,Nicholas Stong,Yumi Nakayama,Lei Wu,Hsiling Chiu,Ann Polonskaia,Samuel A Danziger,Fadi Towfic,Joel Parker,Rebecca L King,Brian K Link,Susan L Slager,Vivekananda Sarangi,Yan W Asmann,Joseph P Novak,Akshay Sudhindra,Stephen M Ansell,Thomas M Habermann,Patrick R Hagner,Grzegorz S Nowakowski,James R Cerhan,Anne J Novak #,Anita K Gandhi #

DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas

DEK调节B细胞增殖能力,并与低级别B细胞淋巴瘤的侵袭性疾病相关。

Melissa A Hopper ,Abigail R Dropik ,Janek S Walker ,Joseph P Novak ,Miranda S Laverty ,Michelle K Manske ,Xiaosheng Wu ,Kerstin Wenzl ,Jordan E Krull ,Vivekananda Sarangi ,Matthew J Maurer ,Zhi-Zhang Yang ,Miles D Del Busso ,Thomas M Habermann ,Brian K Link ,Lisa M Rimsza ,Thomas E Witzig ,Stephen M Ansell ,James R Cerhan ,Dragan Jevremovic ,Anne J Novak

Expanded tumor-associated polymorphonuclear myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activity

华氏巨球蛋白血症中扩增的肿瘤相关多形核髓系来源抑制细胞表现出免疫抑制活性

Vaishali Bhardwaj ,Zhi-Zhang Yang ,Shahrzad Jalali ,Jose C Villasboas ,Rekha Mudappathi ,Junwen Wang ,Prithviraj Mukherjee ,Jonas Paludo ,Xinyi Tang ,Hyo Jin Kim ,Jordan E Krull ,Kerstin Wenzl ,Anne J Novak ,Patrizia Mondello ,Stephen M Ansell

Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era

化学免疫治疗时代 BCL2 突变与滤泡性淋巴瘤结果之间的关系

Cristina Correia, Matthew J Maurer, Samantha J McDonough, Paula A Schneider, Paige E Ross, Anne J Novak, Andrew L Feldman, James R Cerhan, Susan L Slager, Thomas E Witzig, Bruce W Eckloff, Hu Li, Grzegorz S Nowakowski, Scott H Kaufmann

Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma

脾脏边缘区淋巴瘤中 CD26+ 和 CD161+ Treg 的表型、功能及临床意义

Xinyi Tang, Zhi-Zhang Yang, Hyo Jin Kim, Theodora Anagnostou, Yue Yu, Xiaosheng Wu, Jun Chen, Jordan E Krull, Kerstin Wenzl, Patrizia Mondello, Vaishali Bhardwaj, Junwen Wang, Anne J Novak, Stephen M Ansell

Expression of KLRG1 and CD127 defines distinct CD8+ subsets that differentially impact patient outcome in follicular lymphoma

KLRG1 和 CD127 的表达定义了不同的 CD8+ 亚群,对滤泡性淋巴瘤患者的预后产生不同的影响

Hongyan Wu, Xinyi Tang, Hyo Jin Kim, Shahrzad Jalali, Joshua C Pritchett, Jose C Villasboas, Anne J Novak, Zhi-Zhang Yang, Stephen M Ansell

Human Cancers Express TRAILshort, a Dominant Negative TRAIL Splice Variant, Which Impairs Immune Effector Cell Killing of Tumor Cells

人类癌症表达显性负性 TRAIL 剪接变体 TRAILshort,可削弱免疫效应细胞对肿瘤细胞的杀伤作用

Fatma Aboulnasr, Ashton Krogman, Rondell P Graham, Nathan W Cummins, Anisha Misra, Enrique Garcia-Rivera, Jeff R Anderson, Sekar Natesampillai, Nicole Kogan, Murali Aravamudan, Zilin Nie, Thomas D Y Chung, Richard Buick, Andrew L Feldman, Rebecca L King, Anne J Novak, Stephen M Ansell, Saad Kenderia

Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma

针对糖原合酶激酶 3 治疗淋巴瘤

Xiaosheng Wu, Mary Stenson, Jithma Abeykoon, Kevin Nowakowski, Lianwen Zhang, Joshua Lawson, Linda Wellik, Ying Li, Jordan Krull, Kerstin Wenzl, Anne J Novak, Stephen M Ansell, Gail A Bishop, Daniel D Billadeau, Kah Whye Peng, Francis Giles, Daniel M Schmitt, Thomas E Witzig

Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma

通过 PD-L1 的反向信号传导支持经典霍奇金淋巴瘤中的恶性细胞生长和存活

Shahrzad Jalali, Tammy Price-Troska, Cole Bothun, Jose Villasboas, Hyo-Jin Kim, Zhi-Zhang Yang, Anne J Novak, Haidong Dong, Stephen M Ansell